ROIVANT SCIENCES LTD (ROIV)

BMG762791017 - Common Stock

10.94  +0.2 (+1.86%)

After market: 10.7206 -0.22 (-2.01%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
55.29M
132.31%
61.28M
10.83%
124.795M
103.65%
144.74M
15.98%
102.05M
-29.49%
173.22M
69.74%
777.56M
348.89%
1.604B
106.29%
2.72B
69.58%
4.091B
50.40%
5.283B
29.14%
EBITDA
YoY % growth
N/A-1.156B
12.87%
-1.058B
8.52%
-1.09B
-3.07%
-1.114B
-2.20%
-1.17B
-4.99%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-1.352B
-26.22%
-1.175B
13.04%
-1.08B
8.11%
-1.077B
0.27%
-1.137B
-5.53%
-1.087B
4.35%
-352.489M
67.58%
414.45M
217.58%
1.321B
218.74%
2.419B
83.12%
3.965B
63.91%
Operating Margin
-2,444.64%-1,917.95%-865.37%-744.14%-1,113.82%-627.65%-45.33%25.84%48.57%59.13%75.05%
EPS
YoY % growth
N/A-1.59
-8.78%
-1.27
20.13%
-0.75
41.24%
-1.19
-59.52%
-1.19
-0.10%
-0.48
60.05%
0.20
142.15%
1.13
460.90%
2.16
91.85%
3.36
55.43%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.29
4.31%
-0.25
-33.44%
-0.24
-297.63%
-0.29
6.23%
-0.31
-8.97%
-0.35
-38.12%
Revenue
Q2Q % growth
16.31M
-56.09%
39.948M
38.09%
36.939M
-33.00%
20.328M
-30.53%
31.113M
90.76%
29.906M
-25.14%
EBITDA
Q2Q % growth
-312.12M
-15.29%
-266.052M
-9.05%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-293.171M
-1.96%
-264.889M
0.42%
-221.389M
-4.12%
-290.44M
15.00%
-278.661M
4.95%
-368.226M
-39.01%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
-0.31
22.50%
-0.26-0.05-18.60%
Q1 2025
Q2Q % growth
0.12
131.58%
-0.270.39145.25%
Q4 2024
Q2Q % growth
-0.19
5.00%
-0.310.1238.59%
Q3 2024
Q2Q % growth
-0.30
38.78%
-0.330.038.09%
Q2 2024
Q2Q % growth
-0.40
4.76%
-0.31-0.09-27.09%
Q1 2024
Q2Q % growth
-0.38
20.83%
-0.30-0.08-25.18%
Q4 2023
Q2Q % growth
-0.20
25.93%
-0.370.1745.72%
Q3 2023
Q2Q % growth
-0.49
-19.51%
-0.39-0.10-24.27%
Q2 2023
Q2Q % growth
-0.42
-31.25%
-0.420.000.92%
Q1 2023
Q2Q % growth
-0.48 -0.33-0.15-45.52%
Q4 2022
Q2Q % growth
-0.27 -0.330.0617.90%
Q3 2022
Q2Q % growth
-0.41 -0.25-0.16-61.04%
Q2 2022
Q2Q % growth
-0.32 -0.23-0.09-41.00%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2025
Q2Q % growth
29.262M
-21.13%
50.205M-20.943M-41.71%
Q1 2025
Q2Q % growth
55.132M
154.96%
32.131M23.001M71.59%
Q4 2024
Q2Q % growth
28.93M
5.68%
32.144M-3.214M-10.00%
Q3 2024
Q2Q % growth
37.14M
117.83%
32.727M4.413M13.48%
Q2 2024
Q2Q % growth
37.101M
196.10%
27.427M9.674M35.27%
Q1 2024
Q2Q % growth
21.624M
400.56%
25.569M-3.945M-15.43%
Q4 2023
Q2Q % growth
27.376M
196.92%
21.957M5.419M24.68%
Q3 2023
Q2Q % growth
17.05M
-29.95%
15.08M1.97M13.06%
Q2 2023
Q2Q % growth
12.53M
-10.44%
6.516M6.014M92.30%
Q1 2023
Q2Q % growth
4.32M
-44.19%
8.596M-4.276M-49.74%
Q4 2022
Q2Q % growth
9.22M
-39.14%
13.615M-4.395M-32.28%
Q3 2022
Q2Q % growth
24.34M
323.30%
10.063M14.277M141.88%
Q2 2022
Q2Q % growth
13.99M
959.85%
5.403M8.587M158.93%
Q1 2022
Q2Q % growth
7.74M
389.87%
%
Q4 2021
Q2Q % growth
15.15M
163.48%
%
Q3 2021
Q2Q % growth
5.75M
334.62%
%
Q2 2021
Q2Q % growth
1.32M
-16.24%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 1.25% 1.62% 6.79%
Revenue0% -57.54% -12.05% -24.48%